首页|期刊导航|中国医学创新|PVP、基础抗骨质疏松治疗联合补肾健骨方对老年骨质疏松性腰椎压缩骨折患者的效果

PVP、基础抗骨质疏松治疗联合补肾健骨方对老年骨质疏松性腰椎压缩骨折患者的效果OA

Efficacy of PVP,Basic Anti-osteoporosis Therapy Combined with Bushen Jiangu Formula in Elderly Patients with Osteoporotic Lumbar Compression Fracture

中文摘要英文摘要

目的:评价经皮椎体成形术(PVP)、基础抗骨质疏松治疗联合补肾健骨方对老年骨质疏松性腰椎压缩骨折(osteoporotic lumbar compression fracture,OLCF)患者的影响.方法:纳入 2023 年 5 月—2025 年 5 月在西安临潼博仁医院骨科就诊的 70 例老年OLCF患者,以随机数字表法分为对照组(35 例)和治疗组(35 例).两组均行PVP治疗,对照组术后给予碳酸钙D3、阿法骨化醇及阿仑膦酸钠,治疗组在对照组基础上加服补肾健骨方,疗程均为 3 个月.观察并比较两组椎体前缘高度恢复率及治疗前后VAS评分、Oswestry功能障碍指数(ODI)评分、伤椎Cobb角、血清骨形成标志物[Ⅰ型原胶原N-端前肽(P1NP)、骨特异性碱性磷酸酶(BALP)]、骨吸收标志物[Ⅰ型胶原羧基端肽β特殊序列(β-CTX)、抗酒石酸酸性磷酸酶 5b(TRACP-5b)]、不良事件发生情况.结果:本研究期间,脱落与剔除:对照组 3 例,治疗组 2 例,共 65 例患者完成全部研究.治疗后,两组VAS评分、ODI较治疗前降低,伤椎Cobb角较治疗前减小,且治疗组显著优于对照组(P<0.05).治疗组椎体前缘高度恢复率高于对照组(P<0.05).治疗后,两组血清P1NP、BALP水平较治疗前显著升高,血清β-CTX、TRACP-5b水平较治疗前显著降低,治疗组显著优于对照组(P<0.05).治疗期间两组均未出现不良事件.结论:在PVP及基础抗骨质疏松治疗基础上,联合应用补肾健骨方能更有效地减轻老年OLCF患者的疼痛,改善腰椎功能,促进椎体形态恢复,其作用机制可能与双向调节骨代谢、促进骨形成并抑制骨吸收有关.

Objective:To evaluate the effects of percutaneous vertebroplasty(PVP),basic anti-osteoporosis therapy combined with Bushen Jiangu Formula in elderly patients with osteoporotic lumbar compression fracture(OLCF).Method:A total of 70 elderly patients with OLCF who visited the Department of Orthopedics of Xi'an Lintong Boren Hospital from May 2023 to May 2025 were included and divided into the control group(35 cases)and the treatment group(35 cases)by the random number table method.Both groups were treated with PVP.The control group was given Calcium Carbonate D3,Alfacalcidol and Alendronate Sodium after the operation,while the treatment group was given the Bushen Jiangu Formula on the basis of the control group.The treatment course was 3 months for both groups.The recovery rates of the anterior edge height of the vertebral body,as well as the VAS scores,Oswestry disability index(ODI)scores,Cobb angles of the injured vertebrae,serum bone formation markers[procollagen type Ⅰ N-terminal propeptide(P1NP),bone-specific alkaline phosphatase(BALP)],and bone resorption markers[β-C-terminal telopeptide of type Ⅰ collagen(β-CTX),tartrate-resistant acid phosphatase 5b(TRACP-5b)]before and after treatment,occurrence of adverse events were observed and compared.Result:During this study period,dropout and exclusion:3 cases in the control group,2 cases in the treatment group,a total of 65 patients completed the entire study.After treatment,the VAS scores,ODI in both groups decreased than those of before treatment,and Cobb angles of the injured vertebrae were significantly improved compared with those before treatment,and the indexes in the treatment group were significantly better than those in the control group(P<0.05).The recovery rate of anterior vertebral height in the treatment group was higher than that in the control group(P<0.05).After treatment,the levels of serum P1NP and BALP in both groups were significantly increased compared with those before treatment,while the levels of serum β-CTX and TRACP-5b were significantly decreased compared with those before treatment,and the indexes in the treatment group were significantly better than those in the control group(P<0.05).No adverse events occurred in either group during the treatment period.Conclusion:Based on PVP and basic anti-osteoporosis therapy,the additional application of Bushen Jiangu Formula can more effectively relieve pain,improve lumbar function,and promote vertebral morphological recovery in elderly OLCF patients.Its mechanism of action may be related to the bidirectional regulation of bone metabolism,promoting bone formation and inhibiting bone resorption.

崔磊;李鹏飞;刘磊

西安临潼博仁医院骨科 陕西 西安 710600西安临潼博仁医院骨科 陕西 西安 710600西安临潼博仁医院骨科 陕西 西安 710600

医药卫生

骨质疏松性腰椎压缩骨折补肾健骨方骨代谢标志物经皮椎体成形术

Osteoporotic lumbar compression fractureBushen Jiangu FormulaBone metabolism markersPercutaneous vertebroplasty

《中国医学创新》 2026 (19)

35-39,5

10.3969/j.issn.1674-4985.2026.19.008

评论